Session 5 Sialic acid in cancer and immunology
Chair - Patricia Gorocica
14:00-14:20

14:20-14:50

14:50-15:10

15;10-15:30
15:30-15:50
15:50-16:10

Annick Pierce - Université des Sciences et des
Technologies de Lille, France
Crosstalk between posttranslational modifications
regulates delta-lactoferrin antitumoral activities
Keynote: Bo Rueda - Massachusetts General
Hospital, USA
Targeting the Sialyl-Thomsen-nouveau (STn)
antigen to develop treatment strategies for high
grade ovarian cancer
Verónica Vallejo Ruiz - Centro de Investigación
Biomédica de Oriente, Mexico
Human papillomavirus oncoproteins modulate
glycogene expression profiles
Coffee Break
Myron R. Szewczuk - Queen’s University, Canadá
Sialylation facilitates 3D multicellular tumor spheroid
formation and cancer initiation
Keynote: Ken Kitajima, Nagoya University, Japan
Differential fate of medaka fish, Oryzias latipes, with
different point-mutations in the CMP-sialic acid
synthetase gene